Department of Anaesthesia, Indira Gandhi Medical College Shimla, Shimla, India
© 2024 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: AS (Arti Sharma), JP. Methodology: AS (Arti Sharma), JP. Formal analysis: VS, JP. Data curation: VS, AST (Arvind Sethi), JP. Visualization: VS, (Arvind Sethi), JP. Project administration: AS (Arti Sharma), AST (Arvind Sethi), JP. Writing–original draft: all authors. Writing–review & editing: all authors.
Variable | IVC-CI | LVOT-VTI |
---|---|---|
AUC | 0.613 | 0.853 |
SE | 0.073 | 0.049 |
95% CI | 0.509–0.710 | 0.769–0.916 |
P-value | 0.120 | <0.001 |
Difference between areas | 0.233 | |
SE | 0.097 | |
95% CI | 0.044–0.422 | |
P-value | 0.016a) | |
Cutoff | >51.5 | ≤17.45 |
Sensitivity (95% CI, %) | 30.4 (13.2–52.9) | 83.3 (62.6–95.3) |
Specificity (95% CI, %) | 93.3 (85.1–97.8) | 80.3 (69.5–88.5) |
PPV (95% CI, %) | 58.3 (27.7–84.8) | 57.1 (39.4–73.7) |
NPV (95% CI, %) | 81.4 (71.6–89.0) | 93.8 (85.0–98.3) |
Diagnostic accuracy (%) | 73.6 | 77.4 |
Values are presented as number (%) or mean±standard deviation (SD) unless otherwise indicated. Statistical tests used for various parameters: Fisher's exact test (No. 1, 2, 4, 5, 6, 7, 8), chi-square test (No. 3, 9, 11), independent t-test (No.10, 12), Mann-Whitney test (No. 11 IQR value).
COPD: chronic obstructive pulmonary disease; ASA: American Society of Anesthesiologists; IQR: interquartile range; IVC-CI: inferior vena cava collapsibility index; LVOT-VTI: left ventricular outflow tract velocity time integral.
Characteristic | Mean±SD | Median (IQR) | Range |
---|---|---|---|
Age (yr) | 46±10 | 45 (40–54) | 30–60 |
Height (m) | 1.7±0.1 | 1.6 (1.6–1.7) | 1.5–1.9 |
Weight (kg) | 61.9±10.8 | 60.0 (55.0–65.0) | 45.0–105.0 |
Body mass index (kg/m²) | 22.4±4.1 | 21.9 (19.5–24.0) | 16.1–37.6 |
Hemoglobin (g/dl) | 12.7±1.2 | 12.5 (12.0–13.2) | 9.2–15.5 |
Propofol used (mg) | 105.1±14.8 | 100.0 (100.0–120.0) | 80.0–150.0 |
IVC-CI | 40.5±8.4 | 37.7 (33.8–45.7) | 30.8–69.0 |
LVOT-VTI | 17.9±1.2 | 18.1 (16.9–19.0) | 15.3–20.0 |
Variable | IVC-CI | LVOT-VTI |
---|---|---|
AUC | 0.613 | 0.853 |
SE | 0.073 | 0.049 |
95% CI | 0.509–0.710 | 0.769–0.916 |
P-value | 0.120 | <0.001 |
Difference between areas | 0.233 | |
SE | 0.097 | |
95% CI | 0.044–0.422 | |
P-value | 0.016 |
|
Cutoff | >51.5 | ≤17.45 |
Sensitivity (95% CI, %) | 30.4 (13.2–52.9) | 83.3 (62.6–95.3) |
Specificity (95% CI, %) | 93.3 (85.1–97.8) | 80.3 (69.5–88.5) |
PPV (95% CI, %) | 58.3 (27.7–84.8) | 57.1 (39.4–73.7) |
NPV (95% CI, %) | 81.4 (71.6–89.0) | 93.8 (85.0–98.3) |
Diagnostic accuracy (%) | 73.6 | 77.4 |
Serial No. | Parameter | Patients with hypotension (n=24) | Patients without hypotension (n=76) | Total | P-value |
---|---|---|---|---|---|
1 | Asthma | 0 | 2 (2.6) | 2 (2.0) | 1.000 |
2 | Diabetes mellitus | 4 (16.7) | 4 (5.3) | 8 (8.0) | 0.090 |
3 | Hypertension | 6 (25.0) | 5 (6.6) | 11 (11.0) | 0.012 |
4 | COPD | 3 (12.5) | 3 (4.0) | 6 (6.0) | 0.148 |
5 | Obese | 3 (12.5) | 1 (1.3) | 4 (4.0) | 0.042 |
6 | Overweight | 1 (4.2) | 0 | 1 (1.0) | 0.240 |
7 | Hypothyroid | 2 (8.3) | 2 (2.6) | 4 (4.0) | 0.243 |
8 | Anemic | 1 (4.2) | 0 | 1 (1.0) | 0.240 |
9 | ASA I grade | 12 (50.0) | 62 (81.6) | 74 (74.0) | 0.002 |
ASA II grade | 12 (50.0) | 14 (18.4) | 26 (26.0) | ||
10 | Hemoglobin (g/dl) | 12.2±1.3 | 12.8±1.1 | 12.7±1.2 | 0.035 |
Median (IQR) | 12.2 (11.6–12.7) | 12.8 (12.0–13.2) | 12.5 (1.0–13.2) | ||
Range | 9.2–14.6 | 9.8–15.5 | 9.2–15.5 | ||
11 | IVC-CI ≤51.5 | 17 (70.8) | 71 (93.4) | 88 (88.0) | 0.003 |
IVC-CI >51.5 | 7 (29.2) | 5 (6.6) | 12 (12.0) | ||
Mean±SD | 44.1±11.3 | 39.4±7.1 | 40.5±8.4 | 0.102 | |
Median (IQR) | 41.5 (35.4–52.5) | 37.5 (33.5–44.2) | 37.7 (33.8–45.7) | ||
Range | 30.8–69.0 | 31.1–56.4 | 30.8–69.0 | ||
12 | LVOT-VTI ≤17.45 | 20 (83.3) | 15 (19.7) | 35 (35.0) | <0.001 |
LVOT-VTI >17.45 | 4 (16.7) | 61 (80.3) | 65 (65.0) | ||
Mean±SD | 16.8±1.0 | 18.3±1.0 | 17.9±1.2 | <0.001 | |
Median (IQR) | 16.6 (16.1–17.3) | 18.4 (17.6–19.1) | 18.1 (16.9–19.0) | ||
Range | 15.3–19.0 | 15.5–20.0 | 15.3–20.0 |
Variable | Beta coefficient | SE | P-value | OR | 95% CI |
---|---|---|---|---|---|
Hemoglobin (g/dl) | –0.397 | 0.249 | 0.110 | 0.672 | 0.413–1.094 |
Hypertension | 0.938 | 0.943 | 0.320 | 2.555 | 0.403–16.220 |
Obese | 1.414 | 1.839 | 0.442 | 4.111 | 0.112–151.193 |
1 | 1.000 | ||||
2 | 0.530 | 0.737 | 0.473 | 1.698 | 0.400–7.205 |
IVC-CI ≤51.5 | 1.000 | ||||
IVC-CI >51.5 | 2.139 | 0.957 | 0.025 | 8.491 | 1.301–55.414 |
LVOT-VTI >17.45 | 1.000 | ||||
LVOT-VTI ≤17.45 | 2.858 | 0.700 | <0.001 | 17.427 | 4.422–68.672 |
SD: standard deviation; IQR: interquartile range; IVC-CI: inferior vena cava collapsibility index; LVOT-VTI: left ventricular outflow tract velocity time integral.
IVC-CI: inferior vena cava collapsibility index; LVOT-VTI: left ventricular outflow tract velocity time integral; AUC: area under the curve; SE: standard error; CI: confidence interval; PPV: positive predictive value; NPV: negative predictive value. DeLong test.
Values are presented as number (%) or mean±standard deviation (SD) unless otherwise indicated. Statistical tests used for various parameters: Fisher's exact test (No. 1, 2, 4, 5, 6, 7, 8), chi-square test (No. 3, 9, 11), independent t-test (No.10, 12), Mann-Whitney test (No. 11 IQR value). COPD: chronic obstructive pulmonary disease; ASA: American Society of Anesthesiologists; IQR: interquartile range; IVC-CI: inferior vena cava collapsibility index; LVOT-VTI: left ventricular outflow tract velocity time integral.
SE: standard error; OR: odds ratio; CI: confidence interval; IVC-CI: inferior vena cava collapsibility index; LVOT-VTI: left ventricular outflow tract velocity time integral.